Malignant progression in parietal-dominant atrophy subtype of Alzheimer's disease occurs independent of onset age

Neurobiology of Aging

Volumn 47, Issue , 2016, Pages 149-156

  Na, Han Kyu ^a   Kang, Dae Ryong ^b   Kim, Sungsoo ^a   Seo, Sang Won ^c,d   Heilman, Kenneth M ^e   Noh, Young ^f   Na, Duk L ^c,d  

^a Yonsei University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Samsung Medical Center   (South Korea)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f Gachon University   (South Korea)

Author keywords

Alzheimer's disease; Hierarchical clustering; Magnetic resonance imaging; Neuropsychological tests; Rate of progression; Subtypes

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPTH PERCEPTION; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; LANGUAGE; LINEAR MIXED MODEL ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PRIORITY JOURNAL; STATISTICAL MODEL; ATROPHY; BRAIN CORTEX; CLASSIFICATION; COGNITION; DIAGNOSTIC IMAGING; DISEASE COURSE; MIDDLE AGED; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; CEREBRAL CORTEX; COGNITION; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84984858971     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2016.08.001     Document Type: Article

References (48)

1. Ahn, H.J., Chin, J., Park, A., Lee, B.H., Suh, M.K., Seo, S.W., Na, D.L., Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J. Korean Med. Sci. 25 (2010), 1071–1076.
2. Bartzokis, G., Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol. Aging 25 (2004), 5–18 author reply 49–62.
3. Bartzokis, G., Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol. Aging 32 (2011), 1341–1371.
4. Bruner, E., De La Cuetara, J.M., Musso, F., Quantifying patterns of endocranial heat distribution: brain geometry and thermoregulation. Am. J. Hum. Biol. 24 (2012), 753–762.
5. Bruner, E., Jacobs, H.I., Alzheimer's disease: the downside of a highly evolved parietal lobe?. J. Alzheimers Dis. 35 (2013), 227–240.
6. Buckner, R.L., Sepulcre, J., Talukdar, T., Krienen, F.M., Liu, H., Hedden, T., Andrews-Hanna, J.R., Sperling, R.A., Johnson, K.A., Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J. Neurosci. 29 (2009), 1860–1873.
7. Buckner, R.L., Snyder, A.Z., Shannon, B.J., LaRossa, G., Sachs, R., Fotenos, A.F., Sheline, Y.I., Klunk, W.E., Mathis, C.A., Morris, J.C., Mintun, M.A., Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 25 (2005), 7709–7717.
8. Butters, M.A., Lopez, O.L., Becker, J.T., Focal temporal lobe dysfunction in probable Alzheimer's disease predicts a slow rate of cognitive decline. Neurology 46 (1996), 687–692.
9. Cho, H., Jeon, S., Kang, S.J., Lee, J.M., Lee, J.H., Kim, G.H., Shin, J.S., Kim, C.H., Noh, Y., Im, K., Kim, S.T., Chin, J., Seo, S.W., Na, D.L., Longitudinal changes of cortical thickness in early- versus late-onset Alzheimer's disease. Neurobiol. Aging 34 (2013), 1921.e9–1921.e15.
10. Dubois, B., Feldman, H.H., Jacova, C., Hampel, H., Molinuevo, J.L., Blennow, K., DeKosky, S.T., Gauthier, S., Selkoe, D., Bateman, R., Cappa, S., Crutch, S., Engelborghs, S., Frisoni, G.B., Fox, N.C., Galasko, D., Habert, M.O., Jicha, G.A., Nordberg, A., Pasquier, F., Rabinovici, G., Robert, P., Rowe, C., Salloway, S., Sarazin, M., Epelbaum, S., de Souza, L.C., Vellas, B., Visser, P.J., Schneider, L., Stern, Y., Scheltens, P., Cummings, J.L., Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol. 13 (2014), 614–629.
11. Gefen, T., Gasho, K., Rademaker, A., Lalehzari, M., Weintraub, S., Rogalski, E., Wieneke, C., Bigio, E., Geula, C., Mesulam, M.M., Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia. Brain 135 (2012), 1554–1565.
12. Gorno-Tempini, M.L., Hillis, A.E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S.F., Ogar, J.M., Rohrer, J.D., Black, S., Boeve, B.F., Manes, F., Dronkers, N.F., Vandenberghe, R., Rascovsky, K., Patterson, K., Miller, B.L., Knopman, D.S., Hodges, J.R., Mesulam, M.M., Grossman, M., Classification of primary progressive aphasia and its variants. Neurology 76 (2011), 1006–1014.
13. Hashimoto, M., Yasuda, M., Tanimukai, S., Matsui, M., Hirono, N., Kazui, H., Mori, E., Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology 57 (2001), 1461–1466.
14. Hassan, A., Whitwell, J.L., Josephs, K.A., The corticobasal syndrome-Alzheimer's disease conundrum. Expert Rev. Neurother. 11 (2011), 1569–1578.
15. Hirono, N., Hashimoto, M., Yasuda, M., Ishii, K., Sakamoto, S., Kazui, H., Mori, E., The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset. Neurology 58 (2002), 743–750.
16. Hwang, J., Kim, C.M., Jeon, S., Lee, J.M., Hong, Y.J., Roh, J.H., Lee, J.H., Koh, J.Y., Na, D.L., Alzheimer's Disease Neuroimaging, I. Prediction of Alzheimer's disease pathophysiology based on cortical thickness patterns. Alzheimers Dement (Amst). 2 (2016), 58–67.
17. Jacobs, D., Sano, M., Marder, K., Bell, K., Bylsma, F., Lafleche, G., Albert, M., Brandt, J., Stern, Y., Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology 44 (1994), 1215–1220.
18. Jacobs, H.I., Van Boxtel, M.P., Jolles, J., Verhey, F.R., Uylings, H.B., Parietal cortex matters in Alzheimer's disease: an overview of structural, functional and metabolic findings. Neurosci. Biobehav Rev. 36 (2012), 297–309.
19. Janocko, N.J., Brodersen, K.A., Soto-Ortolaza, A.I., Ross, O.A., Liesinger, A.M., Duara, R., Graff-Radford, N.R., Dickson, D.W., Murray, M.E., Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia. Acta Neuropathol. 124 (2012), 681–692.
20. Josephs, K.A., Ahlskog, J.E., Parisi, J.E., Boeve, B.F., Crum, B.A., Giannini, C., Petersen, R.C., Rapidly progressive neurodegenerative dementias. Arch. Neurol. 66 (2009), 201–207.
21. Kang, Y.W., Chang, S.M., Na, D.L., Seoul Neurophsychological Screening Battery: Professional Manual. second ed., 2012, Human Brain Research & Consulting Co., Incheon.
22. Kang, Y.W., Na, D.L., Seoul Neurophsychological Screening Battery: Professional Manual. 2003, Human Brain Research & Consulting Co., Incheon.
23. Kim, H., Na, D.L., Normative data on the Korean version of the Boston Naming Test. J. Clin. Exp. Neuropsychol. 21 (1999), 127–133.
24. Koedam, E.L., Lehmann, M., van der Flier, W.M., Scheltens, P., Pijnenburg, Y.A., Fox, N., Barkhof, F., Wattjes, M.P., Visual assessment of posterior atrophy development of a MRI rating scale. Eur. Radiol. 21 (2011), 2618–2625.
25. Komarova, N.L., Thalhauser, C.J., High degree of heterogeneity in Alzheimer's disease progression patterns. PLoS Comput. Biol., 7, 2011, e1002251.
26. Kouri, N., Whitwell, J.L., Josephs, K.A., Rademakers, R., Dickson, D.W., Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat. Rev. Neurol. 7 (2011), 263–272.
27. Lam, B., Masellis, M., Freedman, M., Stuss, D.T., Black, S.E., Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome. Alzheimers Res. Ther., 5, 2013, 1.
28. Liu, C.C., Kanekiyo, T., Xu, H., Bu, G., Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9 (2013), 106–118.
29. Mayeux, R., Clinical practice. Early Alzheimer's disease. N. Engl. J. Med. 362 (2010), 2194–2201.
30. Mendez, M.F., Ghajarania, M., Perryman, K.M., Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer's disease. Dement Geriatr. Cogn. Disord. 14 (2002), 33–40.
31. Mielke, M.M., Leoutsakos, J.M., Tschanz, J.T., Green, R.C., Tripodis, Y., Corcoran, C.D., Norton, M.C., Lyketsos, C.G., Interaction between vascular factors and the APOE epsilon4 allele in predicting rate of progression in Alzheimer's disease. J. Alzheimers Dis. 26 (2011), 127–134.
32. Monsell, S.E., Kukull, W.A., Roher, A.E., Maarouf, C.L., Serrano, G., Beach, T.G., Caselli, R.J., Montine, T.J., Reiman, E.M., Characterizing apolipoprotein E epsilon4 carriers and noncarriers with the clinical diagnosis of mild to moderate Alzheimer dementia and minimal beta-amyloid peptide plaques. JAMA Neurol. 72 (2015), 1124–1131.
33. Morris, J.C., Edland, S., Clark, C., Galasko, D., Koss, E., Mohs, R., van Belle, G., Fillenbaum, G., Heyman, A., The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 43 (1993), 2457–2465.
34. Murray, M.E., Graff-Radford, N.R., Ross, O.A., Petersen, R.C., Duara, R., Dickson, D.W., Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 10 (2011), 785–796.
35. Noh, Y., Jeon, S., Lee, J.M., Seo, S.W., Kim, G.H., Cho, H., Ye, B.S., Yoon, C.W., Kim, H.J., Chin, J., Park, K.H., Heilman, K.M., Na, D.L., Anatomical heterogeneity of Alzheimer disease: based on cortical thickness on MRIs. Neurology 83 (2014), 1936–1944.
36. Ossenkoppele, R., Zwan, M.D., Tolboom, N., van Assema, D.M., Adriaanse, S.F., Kloet, R.W., Boellaard, R., Windhorst, A.D., Barkhof, F., Lammertsma, A.A., Scheltens, P., van der Flier, W.M., van Berckel, B.N., Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. Brain 135 (2012), 2115–2125.
37. Querfurth, H.W., LaFerla, F.M., Alzheimer's disease. N. Engl. J. Med. 362 (2010), 329–344.
38. Rossor, M.N., Fox, N.C., Mummery, C.J., Schott, J.M., Warren, J.D., The diagnosis of young-onset dementia. Lancet Neurol. 9 (2010), 793–806.
39. Scheltens, N.M., Galindo-Garre, F., Pijnenburg, Y.A., van der Vlies, A.E., Smits, L.L., Koene, T., Teunissen, C.E., Barkhof, F., Wattjes, M.P., Scheltens, P., van der Flier, W.M., The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis. J. Neurol. Neurosurg. Psychiatry 87 (2016), 235–243.
40. Schmidt, C., Redyk, K., Meissner, B., Krack, L., von Ahsen, N., Roeber, S., Kretzschmar, H., Zerr, I., Clinical features of rapidly progressive Alzheimer's disease. Dement Geriatr. Cogn. Disord. 29 (2010), 371–378.
41. Schmidt, C., Wolff, M., Weitz, M., Bartlau, T., Korth, C., Zerr, I., Rapidly progressive Alzheimer disease. Arch. Neurol. 68 (2011), 1124–1130.
42. Smits, L.L., Pijnenburg, Y.A., van der Vlies, A.E., Koedam, E.L., Bouwman, F.H., Reuling, I.E., Scheltens, P., van der Flier, W.M., Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains. Eur. Neuropsychopharmacol. 25 (2015), 1010–1017.
43. Soto, M.E., Andrieu, S., Arbus, C., Ceccaldi, M., Couratier, P., Dantoine, T., Dartigues, J.F., Gillette-Guyonnet, S., Nourhashemi, F., Ousset, P.J., Poncet, M., Portet, F., Touchon, J., Vellas, B., Rapid cognitive decline in Alzheimer's disease. Consensus paper. J. Nutr. Health Aging 12 (2008), 703–713.
44. Taylor, K.I., Probst, A., Miserez, A.R., Monsch, A.U., Tolnay, M., Clinical course of neuropathologically confirmed frontal-variant Alzheimer's disease. Nat. Clin. Pract. Neurol. 4 (2008), 226–232.
45. van der Flier, W.M., Pijnenburg, Y.A., Fox, N.C., Scheltens, P., Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE varepsilon4 allele. Lancet Neurol. 10 (2011), 280–288.
46. Whitwell, J.L., Dickson, D.W., Murray, M.E., Weigand, S.D., Tosakulwong, N., Senjem, M.L., Knopman, D.S., Boeve, B.F., Parisi, J.E., Petersen, R.C., Jack, C.R. Jr., Josephs, K.A., Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study. Lancet Neurol. 11 (2012), 868–877.
47. Woodward, M., Jacova, C., Black, S.E., Kertesz, A., Mackenzie, I.R., Feldman, H., ACCORD Investigator Group. Differentiating the frontal variant of Alzheimer's disease. Int. J. Geriatr. Psychiatry 25 (2010), 732–738.
48. Worsley, K.J., Taylor, J.E., Tomaiuolo, F., Lerch, J., Unified univariate and multivariate random field theory. Neuroimage 23 (2004), S189–S195.